Navigation Links
Dynatronics Announces First Quarter Financial Results

SALT LAKE CITY, Nov. 14, 2013 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced results for its fiscal first quarter ended September 30, 2013.

Net sales in the quarter decreased 2.1% to $7,055,428, compared to $7,206,025 in the same period of the prior year. Net loss for the quarter was $107,784 ($.04 per common share), compared to $51,145 ($.02 per common share) for the prior year period.  The loss was primarily the result of lower sales of products manufactured by third parties, as well as approximately $49,000 in higher R&D costs this quarter associated with the company's new ThermoStim probe, a product expected to launch during the quarter ending December 31, 2013.  All per-share amounts reflect the company's one-for-five reverse stock split, effective December 19, 2012.

"While sales of manufactured capital products and supplies remained even or improved, reduced sales of distributed medical products and supplies, including exercise products, nutritional supplements and taping products, accounted for the decrease in sales for the quarter ended September 30, 2013, compared to the prior year period," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "The continued general economic weakness in our primary markets, combined with uncertainties surrounding the implementation of the Affordable Care Act, have dampened demand and contributed to lower sales numbers.

"To offset these challenges, management has undertaken a plan to significantly expand the company's distribution channels by adding new dealers and sales representatives," Cullimore continued, "To date, we have added more than 30 new sales representatives to our distribution channel. These new representatives are independent direct sales reps and sales reps at newly added independent dealers. They will augment our geographical reach to practitioners across the country. The addition of these new reps brings us nearly halfway to our goal of adding 75 new sales representatives selling our products."

"We've also developed a major new product that we expect to introduce in the quarter ending December 31, 2013," reported Larry K. Beardall, executive vice president of sales and marketing. "This is the Dynatron Thermostim Probe™, and will be one of the most innovative and attractive products in our history. The Thermostim Probe is a soft-tissue mobilization tool that also allows a practitioner to deliver heat or cold therapy in combination with electrical stimulation – all at the same time."The new hand-held probe is an accessory to the Dynatron SolarisPlus family of products. It utilizes a thermoelectric chip to generate the thermal therapy and is powered by any one of four Dynatron SolarisPlus units.

"Demand for this innovative probe is building even before it is released," stated Beardall. "We now have indications of interest from over 500 clinicians across the country who have become aware of this innovative new product. And since the probe is operated from the control console of the SolarisPlus units, we expect demand for SolarisPlus units to rise commensurate with the demand for the ThermoStim probe."

"We believe the introduction of the new Thermostim probe, together with the expansion of our distribution channel, will be the impetus to return Dynatronics to profitability," Cullimore concluded.

Dynatronics has scheduled a conference call for investors today, Thursday, November 14, 2013, at 12:30 p.m. ET. Those wishing to participate should call (800) 954-0586.

The following is a summary of the financial results as of September 30, 2013 and 2012, and for the quarter then ended:  Summary Selected Financial DataStatement of Operations HighlightsThree Months Ended
September 30,20132012Net sales


7,055,4287,206,025Cost of sales4,474,3594,495,177Gross profit2,581,0692,710,848Selling, general, and administrative expenses2,379,3692,459,104Research and development expenses314,823266,268Total other expense55,38659,085Loss before income tax benefit (168,509)(73,609)Income tax benefit 60,72522,464Net  loss


(107,784)(51,145)Diluted net loss per common share


(0.04)(0.02) Balance Sheet Highlights As of September 30,20132012Cash and cash equivalents


220,660302,050Trade accounts receivable3,256,4323,246,712Inventories, net6,255,3176,407,553Total current assets10,748,42410,879,449Total assets


14,900,15615,104,587Line of credit3,616,6013,496,390Accounts payable2,453,4412,751,894Accrued expenses388,855347,221Accrued payroll and benefits expense325,318216,266Total liabilities8,781,0718,895,637Total liabilities and stockholders' equity


14,900,15615,104,587About Dynatronics Corporation:Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at

Safe Harbor NotificationThis press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product introductions and plans to expand distribution. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates, and the risk factors listed from time to time in the company's SEC reports.

SOURCE Dynatronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics To Release Fiscal First Quarter Results Thursday, November 14, 2013;
2. Dynatronics Announced Changes in Todays Conference Call Monday, September 30, 2013; Conference Call set for 4:30 p.m. ET
3. Dynatronics Announces Year-End Financial Results
4. Dynatronics To Release Fiscal 2013 Year-end Results Monday, September 30, 2013; Conference Call set for 3:30 p.m. ET
5. Dynatronics Appoints R. Scott Ward, PT PhD to its Board of Directors
6. Dynatronics Announces Third Quarter Results
7. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 14, 2013; Conference Call set for 1:30 p.m. ET
8. Dynatronics Second Quarter Profits Jump 204%
9. Dynatronics To Release Fiscal Second Quarter Results Wednesday, February 13, 2013; Conference Call set for 3:00 p.m. ET
10. Dynatronics Announces First Quarter Results
11. Dynatronics To Release Fiscal First Quarter Results Wednesday, November 14, 2012; Conference Call set for 4:30 p.m. ET
Post Your Comments:
(Date:10/9/2015)... October 9, 2015 ... The report summarizes key statistics ... status of the manufacturers making it ... direction for companies and individuals interested ... . --> ...
(Date:10/9/2015)... N.Y. , Oct. 9, 2015 ... world,s largest provider of health care products and services ... reminded its customers that the Henry Schein Disaster Relief ... experience operational, logistical or financial issues as a result ... . The toll-free number for all Henry ...
(Date:10/9/2015)... 9, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 3 clinical study of telotristat etiprate has been accepted for ... to be held from October 15-17, in Austin, ... who completed the randomized treatment portion of the TELESTAR study ... session. --> --> Telotristat ...
Breaking Medicine Technology:
... , SARASOTA, Fla., Nov. 6 Roper Industries, ... it has signed a definitive agreement to acquire Verathon, ... The Verathon Board of Directors has approved the transaction ... and closing conditions, including shareholder approval. The parties ...
... Companies (ASMC), an informal working group of mid-market and ... 3962, the "Affordable Health Care for America Act," introduced ... fear that the cumulative effect of a host of ... bring new medicines to market. , From ...
Cached Medicine Technology:
(Date:10/9/2015)... Beach, CA (PRWEB) , ... October 09, 2015 ... ... is now offering a special promotion on Invisalign, the orthodontic system that uses ... reasons. The aligners are almost invisible against the teeth, which allow patients to ...
(Date:10/9/2015)... ... October 09, 2015 , ... On Saturday, September 26, ... Jump Rope Championship in Madrid, Spain. Representing both the USA and Sweden in the ... Unders and One-Minute Am Front Crosses, she was awarded 1 Silver and 4 Gold ...
(Date:10/9/2015)... , ... October 09, 2015 , ... ... New Orleans and the surrounding communities, is initiating a combined charity effort with ... for unwanted animals in southern Louisiana. , Animal Rescue New Orleans is ...
(Date:10/9/2015)... , ... October 09, 2015 , ... ... upcoming episode of Innovations with Ed Begley Jr., airing 1st QT 2016 via ... will educate audiences on MMJ Phytotech Limited (MMJ) – a global leader in ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... oldest and largest recreational dispensaries in Colorado, says the latest figures on the ... rapidly and maturing into a legitimate industry. , Last month, according to ...
Breaking Medicine News(10 mins):
... of Medicine (BUSM) have found that some medical inpatients ... intervention. The BUSM study appears in the May issue ... . , "Brief intervention shows promise for increasing receipt ... cognitive functioning or an alcohol- attributable diagnosis," said lead ...
... on human genome , , THURSDAY, April 23 (HealthDay News) -- ... has succeeded in sequencing the entire genome of the placid, ... biology of this bovine and related creatures (even humans), and ... two reports in the April 24 issue of Science ...
... Harvard Medical School today announced the launch ... cancer and other prostate conditions understand the issues related ... treatment. The website, , was ... medical oncology and urologic cancer. This website is especially ...
... Keeping Michigan Workers Working!LANSING, Mich., April 23 May ... MICHIGAN will hold a summit involving 120 of Michigan,s ... Workability in Michigan, , ... professions and organizations who are passionate about promoting safer, ...
... MR procedure that uses diffusion-weighted imaging (DWI) to determine ... benign may help reduce unnecessary breast biopsies, according to ... in Bethesda, MD. DWI is a method that produces ... compartments (diffusion). , The study included 80 patients ...
... tubo ovarian abscesses help women avoid surgery, according to ... MA. Tubo ovarian abscesses (TOAs) are an infected collection ... They can occur in patients with complicated cases of ... study included 54 TOAs in 46 patients. Results showed ...
Cached Medicine News:
... Sensor Intravascular Mikro-Tip Pressure Catheters; Millar ... dual pressure sensor catheters for simultaneous ... are suitable for measuring pressure gradients ... across a vascular stenosis. The catheters ...
... the United States dying from Sudden Cardiac Death ... recommended that AEDs be used as a standard ... Any AED can provide a life-saving shock during ... continuous monitoring capabilities during and after resuscitation. Plus ...
... These catheters are indicated ... soft emboli and thrombi from ... These catheters may also be ... blood vessels, infusion of fluids, ...
... catheter is designed to remove thrombus ... saline jets travel backwards at half ... a low pressure zone causing a ... the catheter where it is fragmented ...
Medicine Products: